Loading clinical trials...
Loading clinical trials...
Multicenter, Open-label, Randomized, Controlled Phase III Clinical Study of the Efficacy and Safety of Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma
Conditions
Interventions
Photodynamic therapy-Photofrin
Stenting procedure
+1 more
Locations
31
United States
Western Regional Medical Center, Inc.
Goodyear, Arizona, United States
Mayo Clinic Cancer Center
Scottsdale, Arizona, United States
University of Southern California Keck School of Medicine
Los Angeles, California, United States
UC Davis Medical Center
Sacramento, California, United States
University of Colorado Denver
Aurora, Colorado, United States
Oschner Medical Center
Kenner, Louisiana, United States
Start Date
November 12, 2014
Primary Completion Date
January 12, 2017
Completion Date
January 12, 2017
Last Updated
August 28, 2019
NCT05430698
NCT05564403
NCT06178588
NCT05563870
NCT07471165
NCT07161869
Lead Sponsor
Concordia Laboratories Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions